can you keep weight off after semaglutide Semaglutide: 5 Strategies Semaglutide (Ozempic® & Wegovy®) Before

Description

[DOI] [PubMed] [Google Scholar] Brom M, Oyen WJ, Joosten L, Gotthardt M, Boerman OC

[DOI] [PubMed] [Google Scholar] 99.Liu, F., Wu, Q., Dong, Z

File File history File usage on Commons File usage on other wikis Metadata Original file (1,419 1,030 pixels, file size: 369 KB, MIME type: image/png) File information Structured data Captions Captions Add a one-line explanation of what this file represents I, the copyright holder of this work, hereby publish it under the following license: You are free: to share to copy, distribute and transmit the work to remix to adapt the work Under the following conditions: attribution You must give appropriate credit, provide a link to the license, and indicate if changes were made

Secondary, safety and negative control endpoints For individual components of the primary endpoint, semaglutide versus sitagliptin reduced myocardial infarction (HR 0.81, 95% CI 0.70 to 0.92) and stroke (HR 0.84, 95% CI 0.71 to 0.99) in the expanded populations at low, moderate and high cardiovascular risk